## **Core Concept**
Allograft rejection is an immune response mounted by the recipient's body against a transplanted organ or tissue from a genetically non-identical donor. This phenomenon is primarily driven by the recognition of **major histocompatibility complex (MHC) molecules** on the surface of the donor cells as foreign by the recipient's immune system. The immune response involves various cell types and cytokines, leading to inflammation and damage to the graft.

## **Why the Correct Answer is Right**
The correct answer, , involves **cell-mediated immunity** and **humoral immunity**, where T cells and B cells play crucial roles. T cells recognize the MHC molecules on antigen-presenting cells (APCs) of the graft, leading to the activation of various immune cells and the release of cytokines. This orchestrated response results in the recruitment of more immune cells to the graft site, causing damage and dysfunction. The involvement of both cellular and humoral arms of the immune system makes it a comprehensive immune response.

## **Why Each Wrong Option is Incorrect**
- **Option A:** - This option is incorrect because allograft rejection is not primarily an example of **innate immunity**, which provides immediate defense against infection and is non-specific. While innate immunity cells may be involved in the initial response, the rejection process is mainly driven by adaptive immune responses.
- **Option B:** - This option is incorrect because **tolerance** refers to the immune system's ability to recognize self-antigens without an immune response. Allograft rejection is the opposite of tolerance, where the immune system does recognize and respond to the graft as foreign.
- **Option C:** - This option might seem plausible but is less directly related compared to . While **autoimmunity** involves an immune response against self-antigens, allograft rejection involves an immune response against non-self antigens.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that ** immunosuppressive drugs** are used to prevent or mitigate allograft rejection by dampening the immune response. These drugs can target various aspects of the immune response, including T cell activation and proliferation. Understanding the mechanisms of allograft rejection and the strategies to prevent it is crucial for managing transplant patients.

## **Correct Answer:** .